EUVIMEDEUVIMED entdecken
Crossref

Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing

Yong Zhang, Runze Liu, Yong Zhang, Zhongbao Zhou

Urologia Internationalis · 2025

DOI: 10.1159/000543983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urologia Internationalis, 2025. Verfasst von Yong Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Organoids, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bladder urothelial carcinoma is highly heterogeneous and is prone to recurrence. There are many types of drugs for intravesical instillation, and there is an urgent need for reliable tumor models for individualized treatment strategies. Patient-derived organoids (PDOs) are efficient and accurate neotype tumor models that can compensate for the deficiencies of traditional tumor models.

Methods

From September 2023 to February 2024, bladder cancer tissues were collected from surgical resections in the Department of Urology, Beijing Tiantan Hospital, Capital Medical University. We explored suitable culture systems and cultured primary tumor cells in Matrigel matrix gels. Hematoxylin and eosin (HE) staining and immunohistochemistry were performed for comparison with the original tumor tissue at the histological level for validation. Drug sensitivity tests were also conducted.

Results

In this study, a culture system for PDOs was successfully established. HE staining and immunohistochemistry were used to morphologically verify the organ model. Drug sensitivity tests have clarified the value of PDOs as preclinical models of precision medicine.

Conclusion

A bladder tumor PDO culture platform was initially established, which laid a foundation for the subsequent construction of the organoid bank, the study of bladder tumor progression mechanism, and research in precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsOrganoidsAntineoplastic AgentsHumansDrug Screening Assays, AntitumorMaleFemaleMiddle AgedTumor Cells, Cultured

Stichwörter der Autor:innen

Bladder cancerIndividualized therapyOrganoidUrothelial carcinoma

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, liurunze910@outlook.com.

Zitieren

APA

Zhang, Y., Liu, R., Zhang, Y., & Zhou, Z. (2025). Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing. Urologia Internationalis. https://doi.org/10.1159/000543983

Vancouver

Zhang Y, Liu R, Zhang Y, Zhou Z. Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing. Urologia Internationalis. 2025. doi:10.1159/000543983

BibTeX
@article{Zhang2025,
  author = {Zhang, Yong and Liu, Runze and Zhang, Yong and Zhou, Zhongbao},
  title = {Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing},
  journal = {Urologia Internationalis},
  year = {2025},
  doi = {10.1159/000543983}
}
Kostenlos starten →